Michael R Verneris

Summary

Affiliation: Stanford University
Country: USA

Publications

  1. ncbi request reprint Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice
    Michael R Verneris
    Division of Pediatric Hematology Oncology, and Bone Marrow Transplantation, Stanford, California 94305, USA
    J Clin Immunol 22:131-6. 2002
  2. ncbi request reprint Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells
    Mobin Karimi
    Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Immunol 175:7819-28. 2005
  3. ncbi request reprint Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging
    Matthias Edinger
    Division of Bone Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, CA, USA
    Blood 101:640-8. 2003
  4. ncbi request reprint Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
    Michael R Verneris
    Division of Pediatric Blood and Marrow Diseases, University of Minnesota, Minneapolis, MN 55455, USA
    Blood 103:3065-72. 2004
  5. pmc Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells
    Bartosz Grzywacz
    Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, 425 E River Rd, Suite 660, Minneapolis, MN 55455, USA
    Blood 108:3824-33. 2006
  6. ncbi request reprint iTRAQ is a useful method to screen for membrane-bound proteins differentially expressed in human natural killer cell types
    Troy C Lund
    Department of Medicine, Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 670 CCRB, 425 East River Road, Minneapolis, MN 55455, USA
    J Proteome Res 6:644-53. 2007
  7. pmc Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
    Jeffery S Miller
    Divisions of Adult and Pediatric Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Harvard Street at East River Road, Minneapolis, MN 55455, USA
    Blood 109:5058-61. 2007
  8. pmc The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations
    Hongbo Wang
    Department of Pediatrics, Cancer Center, University of Minnesota, Minneapolis, USA
    Blood 110:1530-9. 2007
  9. pmc Use of natural killer cells as immunotherapy for leukaemia
    Bartosz Grzywacz
    Division of Blood and Marrow Transplantation, University of Minnesota, MN, USA
    Best Pract Res Clin Haematol 21:467-83. 2008

Collaborators

Detail Information

Publications9

  1. ncbi request reprint Studies of ex vivo activated and expanded CD8+ NK-T cells in humans and mice
    Michael R Verneris
    Division of Pediatric Hematology Oncology, and Bone Marrow Transplantation, Stanford, California 94305, USA
    J Clin Immunol 22:131-6. 2002
    ..We conclude that expanded CD8+ NK-T cells are a promising form of cellular therapy in the allogeneic setting...
  2. ncbi request reprint Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells
    Mobin Karimi
    Division of Blood and Marrow Transplantation, Stanford University School of Medicine, Stanford, CA 94305, USA
    J Immunol 175:7819-28. 2005
    ..These studies demonstrated the importance of NKG2D, DAP10, and DAP12 in human effector cell function...
  3. ncbi request reprint Revealing lymphoma growth and the efficacy of immune cell therapies using in vivo bioluminescence imaging
    Matthias Edinger
    Division of Bone Marrow Transplantation, Department of Medicine, Stanford University School of Medicine, CA, USA
    Blood 101:640-8. 2003
    ..The complex cellular processes in bone marrow transplantation and antitumor immunotherapy, previously inaccessible to investigation, can now be revealed in real time in living animals...
  4. ncbi request reprint Role of NKG2D signaling in the cytotoxicity of activated and expanded CD8+ T cells
    Michael R Verneris
    Division of Pediatric Blood and Marrow Diseases, University of Minnesota, Minneapolis, MN 55455, USA
    Blood 103:3065-72. 2004
    ..Collectively these results establish that NKG2D triggering accounts for the majority of major histocompatibility complex (MHC)-unrestricted cytotoxicity of activated and expanded CD8+ T cells, likely through DAP10-mediated signaling...
  5. pmc Coordinated acquisition of inhibitory and activating receptors and functional properties by developing human natural killer cells
    Bartosz Grzywacz
    Department of Pediatrics, Division of Blood and Marrow Transplantation, University of Minnesota, 425 E River Rd, Suite 660, Minneapolis, MN 55455, USA
    Blood 108:3824-33. 2006
    ..The identified stages of NK-cell differentiation provide evidence for coordinated acquisition of HLA-specific inhibitory receptors (ie, CD94/NKG2A) and function in developing human NK cells...
  6. ncbi request reprint iTRAQ is a useful method to screen for membrane-bound proteins differentially expressed in human natural killer cell types
    Troy C Lund
    Department of Medicine, Department of Biochemistry, Molecular Biology, and Biophysics, University of Minnesota, 670 CCRB, 425 East River Road, Minneapolis, MN 55455, USA
    J Proteome Res 6:644-53. 2007
    ..This is the first demonstration and verification using iTRAQ to screen for membrane-bound protein differences in human NK cells and represents a powerful new tool in the field of proteomics...
  7. pmc Missing KIR ligands are associated with less relapse and increased graft-versus-host disease (GVHD) following unrelated donor allogeneic HCT
    Jeffery S Miller
    Divisions of Adult and Pediatric Hematology, Oncology and Transplantation, University of Minnesota Cancer Center, Harvard Street at East River Road, Minneapolis, MN 55455, USA
    Blood 109:5058-61. 2007
    ..58, 95% CI 1.13-2.22; P = .008). These data support a genetically determined role for NK cells following unrelated HCT in myeloid leukemia...
  8. pmc The unexpected effect of cyclosporin A on CD56+CD16- and CD56+CD16+ natural killer cell subpopulations
    Hongbo Wang
    Department of Pediatrics, Cancer Center, University of Minnesota, Minneapolis, USA
    Blood 110:1530-9. 2007
    ..Collectively, these studies show that CSA influences NK-cell function and phenotype, which may have important implications for graft-versus-leukemia effects...
  9. pmc Use of natural killer cells as immunotherapy for leukaemia
    Bartosz Grzywacz
    Division of Blood and Marrow Transplantation, University of Minnesota, MN, USA
    Best Pract Res Clin Haematol 21:467-83. 2008
    ..Future modifications to improve NK cell adoptive immunotherapy by means of increasing target recognition and reducing inhibitory signalling are being explored...